Low affinity binding of the classical D1 antagonist SCH23390 in rodent brain: Potential interaction with A2A and D2-like receptors

Brain Research

Volumn 1117, Issue 1, 2006, Pages 25-37

  Leonard, Sarah K ^a   Ferry Leeper, Penelope ^a   Mailman, Richard B ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Adenosine receptor; Dopamine receptor; Heteromerization; Knockout mice; Radioreceptor binding

Indexed keywords

5 AMINO 2 (2 FURYL) 7 (2 PHENYLETHYL)PYRAZOLO[4,3 E][1,2,4]TRIAZOLO[1,5 C]PYRIMIDINE; 8 (3 CHLOROSTYRYL)CAFFEINE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; ADENOSINE 5' (N ETHYLCARBOXAMIDE); ADENOSINE A2A RECEPTOR; BUTACLAMOL; CHLORPROMAZINE; CLOZAPINE; DOMPERIDONE; DOPAMINE 1 RECEPTOR BLOCKING AGENT; DOPAMINE 2 RECEPTOR; FLUPENTIXOL; FLUPHENAZINE; IDAZOXAN; LIGAND; MAGNESIUM CHLORIDE; THIORIDAZINE; TRITIUM;

ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BINDING SITE; BRAIN; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE RELEASE; DRUG RECEPTOR BINDING; FEMALE; HIPPOCAMPUS; IN VITRO STUDY; MALE; MOLECULAR INTERACTION; MOUSE; NONHUMAN; OBSERVATION; PRIORITY JOURNAL; RADIOASSAY; RAT; RECEPTOR OCCUPANCY;

(R)-2,3,4,5-TETRAHYDRO-8-CHLORO-3-METHYL-5-PHENYL-1H-3-BENZAZEPIN-7-OL; ADENOSINE; ANIMALS; BENZAZEPINES; BINDING SITES; BINDING, COMPETITIVE; BRAIN; DOMPERIDONE; DOPAMINE; DOPAMINE ANTAGONISTS; FEMALE; HELA CELLS; HUMANS; MAGNESIUM CHLORIDE; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RADIOLIGAND ASSAY; RATS; RECEPTOR AGGREGATION; RECEPTOR, ADENOSINE A2A; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; RECEPTORS, SEROTONIN;

ANIMALIA; RODENTIA;

EID: 33749997794     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2006.08.024     Document Type: Article

References (56)

1. 2 and D3 dopamine receptor cell surface localization mediated by interaction with protein 4.1N. Mol. Pharmacol. 62 (2002) 507-513
2. Blair J.L., Warner D.S., and Todd M.M. Effects of elevated plasma magnesium versus calcium on cerebral ischemic injury in rats. Stroke 20 (1989) 507-512
3. 1-like receptor antagonist. CNS Drug Rev. 7 (2001) 399-414
4. 2 subtypes of dopamine receptors in rat brain. J. Neurosci. 6 (1986) 3177-3188
5. Caine S.B., Heinrichs S.C., Coffin V.L., and Koob G.F. Effects of the dopamine D-1 antagonist SCH 23390 microinjected into the accumbens, amygdala or striatum on cocaine self-administration in the rat. Brain Res. 692 (1995) 47-56
6. 1 receptor blockade in the amygdala. Pharmacol. Biochem. Behav. 51 (1995) 759-766
7. 2 receptor-receptor heteromerization: qualitative and quantitative assessment by fluorescence and bioluminescence energy transfer. J. Biol. Chem. 278 (2003) 46741-46749
8. Chen J.F., Huang Z., Ma J., Zhu J., Moratalla R., Standaert D., Moskowitz M.A., Fink J.S., and Schwarzschild M.A. A(2A) adenosine receptor deficiency attenuates brain injury induced by transient focal ischemia in mice. J. Neurosci. 19 (1999) 9192-9200
9. 2 receptor knockout mice. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 1970-1975
10. I) and the concentration of inhibitor which causes 50 percent inhibition (I50) of an enzymatic reaction. Biochem. Pharmacol. 22 (1973) 3099-3108
11. 5 receptor immunolocalization in rat and monkey brain. Synapse 37 (2000) 125-145
12. 1 dopamine receptor in the rat brain: quantitative autoradiographic localization using an iodinated ligand. Neuroscience 26 (1988) 83-100
13. 2 receptors for dopamine in human striatum. NeuroReport 12 (2001) 1831-1834
14. 1A dopamine receptors. Proc. Natl. Acad. Sci. U. S. A. 91 (1994) 12564-12568
15. 2 receptors in rat striatal membranes. Proc. Natl. Acad. Sci. U. S. A. 88 (1991) 7238-7241
16. Franco R., Ferre S., Agnati L., Torvinen M., Gines S., Hillion J., Casado V., Lledo P.M., Zoli M., Lluis C., and Fuxe K. Evidence for adenosine/dopamine receptor interactions: indications for heteromerization. Neuropsychopharmacology 23 (2000) S50-S59
17. 1A knockout mice. Mol. Pharmacol. 51 (1997) 6-11
18. Garau L., Govoni S., Stefanini E., Trabucchi M., and Spano P.F. Dopamine receptors: pharmacological and anatomical evidences indicate that two distinct dopamine receptor populations are present in rat striatum. Life Sci. 23 (1978) 1745-1750
19. 2 receptor ligands in a Chinese hamster ovary hD2L cell line: evidence for induction of ligand-specific receptor states. Mol. Pharmacol. 66 (2004) 97-105
20. 1 receptor antagonist SCH 23390 blocks fear-potentiated startle but not shock reactivity or the shock sensitization of acoustic startle. Behav. Neurosci. 114 (2000) 262-272
21. Griffon N., Jeanneteau F., Prieur F., Diaz J., and Sokoloff P. CLIC6, a member of the intracellular chloride channel family, interacts with dopamine D(2)-like receptors. Brain Res. Mol. Brain Res. 117 (2003) 47-57
22. Heffner T.G., Hartman J.A., and Seiden L.S. A rapid method for the regional dissection of the rat brain. Pharmacol. Biochem. Behav. 13 (1980) 453-456
23. 2 receptors. J. Biol. Chem. 277 (2002) 18091-18097
24. 5 receptor null mutant mice. Behav. Neurosci. 115 (2001) 1129-1144
25. 1 dopamine receptor in rat brain reveals its axonal transport, pre- and postsynaptic localization, and prevalence in the basal ganglia, limbic system, and thalamic reticular nucleus. Proc. Natl. Acad. Sci. U. S. A. 89 (1992) 11988-11992
26. 2 dopamine receptor mRNA expression in whole hemisphere sections of the human brain. J. Chem. Neuroanat. 22 (2001) 127-137
27. 2, D3 but not D4 receptors define a novel mode of regulation of G protein-coupled receptors. Mol. Biol. Cell 15 (2004) 696-705
28. Jeong S.M., Hahm K.D., Shin J.W., Leem J.G., Lee C., and Han S.M. Changes in magnesium concentration in the serum and cerebrospinal fluid of neuropathic rats. Acta Anaesthesiol. Scand. 50 (2006) 211-216
29. Jin L.Q., Cai G., Wang H.Y., Smith C., and Friedman E. Characterization of the phosphoinositide-linked dopamine receptor in a mouse hippocampal-neuroblastoma hybrid cell line. J. Neurochem. 71 (1998) 1935-1943
30. 1 dopamine receptors couple to multiple Galpha proteins in different brain regions. J. Neurochem. 78 (2001) 981-990
31. 2 and D3 receptors. Neuroscience 91 (1999) 911-924
32. Kebabian J.W., and Calne D.B. Multiple receptors for dopamine. Nature 277 (1979) 93-96
33. 5 receptors of rat and human brain. Neuroscience 100 (2000) 689-699
34. Kilts C.D., Anderson C.M., Ely T.D., and Mailman R.B. The biochemistry and pharmacology of mesoamygdaloid dopamine neurons. Ann. N. Y. Acad. Sci. 537 (1988) 173-187
35. Latini S., Pazzagli M., Pepeu G., and Pedata F. A2 adenosine receptors: their presence and neuromodulatory role in the central nervous system. Gen. Pharmacol. 27 (1996) 925-933
36. 1 receptor. Cell 111 (2002) 219-230
37. 1 receptors are not linked to stimulation of adenylate cyclase. Synapse 50 (2003) 320-333
38. 1 dopamine receptors in the amygdala exhibit unique properties. Ann. N. Y. Acad. Sci. 985 (2003) 536-539
39. 1 dopamine receptor: its linkage to adenylate cyclase and psychopharmacological effects. Psychopharmacol. Bull. 22 (1986) 593-598
40. 1 receptor binding and mRNA in rat brain using receptor autoradiographic and in situ hybridization techniques. Neuroscience 46 (1992) 959-971
41. 1-deficient mutant mice do not express the late phase of hippocampal long-term potentiation. NeuroReport 8 (1997) 3533-3535
42. 1A receptor-deficient mice. Synapse 39 (2001) 319-322
43. 5 dopamine receptor activation increases the magnitude of early long-term potentiation at CA1 hippocampal synapses. J. Neurosci. 16 (1996) 7478-7486
44. 5 dopamine receptor activation increases the magnitude of early long-term potentiation at CA1 hippocampal synapses. J. Neurosci. 16 (1996) 7478-7486
45. Palkovits M., and Brownstein M. Microdissection of brain areas by the punch technique. In: Cuello A.C. (Ed). Brain Microdissection Techniques (1983), Wiley, New York 1-36
46. Paxinos G., and Watson C. The Rat Brain in Stereotaxic Coordinates (1986), Academic Press, Sydney
47. Rocheville M., Lange D.C., Kumar U., Patel S.C., Patel R.C., and Patel Y.C. Receptors for dopamine and somatostatin: formation of hetero-oligomers with enhanced functional activity. Science 288 (2000) 154-157
48. 3H]SCH 23390. Brain Res. 375 (1986) 291-301
49. 2 dopamine receptors. J. Neurochem. 68 (1997) 1990-1997
50. 1-like dopamine receptor. J. Neurochem. 45 (1985) 1601-1611
51. 1 receptor encoded by an intronless gene on chromosome 5. Nature 347 (1990) 80-83
52. 2A receptor. J. Mol. Neurosci. 24 (2004) 173-180
53. 3 heteromeric complexes. Mol. Pharmacol. 67 (2005) 400-407
54. Undie A.S., and Friedman E. Selective dopaminergic mechanism of dopamine and SKF38393 stimulation of inositol phosphate formation in rat brain. Eur. J. Pharmacol. 226 (1992) 297-302
55. 1 receptors in human brain: a PET study. Synapse 30 (1998) 56-61
56. Wyrick S.D., and Mailman R.B. Tritium-labeled (+)-7-chloro-8-hydroxy-3-methyl-1-phenyl-2,3,4, 5-tetrahydro-1H-3-benzazepine (SCH23390). J. Label. Compd. Radiopharm. 22 (1985) 189-195